Results 151 to 160 of about 106,261 (297)

Chronic Kidney Disease in Dogs in UK Veterinary Practices: Prevalence, Risk Factors, and Survival [PDF]

, 2013
Bartges, Bartges, Bartges, Bartlett, Bartlett, Bronden, Brown, Chandler, Chen, DiBartola, DiBartola, Doherr, Dohoo, Drobatz, Egenvall, Elliott, Elliott, Gardner, Glickman, Grauer, Gregory, Heinze, Hosmer, Jones, Kirkwood, Lees, Lees, Liberg, Ling, Lund, Macdougall, Marinelli, McAloose, McV Messam, Müller-Peddinghaus, Nelson, Nicolle, Oliver, Polzin, Polzin, Schiffrin, Sosnar, Su, Tenhündfeld, The VeNom Coding Group, Thomas, Upjohn, Vaden, Vleck   +48 more
core   +2 more sources

Longitudinal Study of Frailty Phenotype in Relation to Chronic Kidney Disease Incidence

Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 3, June 2026.
ABSTRACT Background The longitudinal relationship between frailty phenotype and CKD development, and the modifying role of genetic CKD risk in this association, remains unclear. Research on simple, noninvasive and quantifiable CKD prediction models incorporating frailty is limited.
Yong‐Xiang Ruan, Da‐Chuan Guo, Wen‐Hao Liu, Jia‐Man Ou, Qi Guo, Jing‐Wei Gao, Yang‐Wei Cai, Mao‐Xiong Wu, Xiao‐Tian Liang, Jie‐Wen Cai, Pin‐Ming Liu, Jing‐Feng Wang, Hai‐Feng Zhang, Yang‐Xin Chen   +13 more
wiley   +1 more source

Examining Referral Pathways for Patients with Hematuria: A Real-World Retrospective Analysis. [PDF]

Glomerular Dis
Chang AR, Hu Y, Brubaker L, Green J, Zafar W, Ndife B, Aldworth C.   +6 more
europepmc   +1 more source

Real‐World Patient Characteristics and Treatment Patterns Among Patients With Interstitial Cystitis (IC)/Bladder Pain Syndrome (BPS)

Reproductive, Female and Child Health, Volume 5, Issue 2, June 2026.
ABSTRACT Objective Interstitial cystitis/bladder pain syndrome (IC/BPS) is linked to bladder and/or pelvic pain, pressure, and discomfort with urinary frequency. Despite guidelines, there is a need for better treatment options. This study analyzed patient demographics, clinical characteristics, and treatment patterns for medications and procedures in ...
Jaromir Mikl, Tiange Yu, Benjamin T. Carter, Andrew Rava, Xin Zhao, Catherine Allende, Amie Devlin, Valentine Pascale, Roger Dmochowski   +8 more
wiley   +1 more source

Obstructive Pyelonephritis With Enterococcal Bacteremia Despite Unremarkable Urinalysis. [PDF]

Cureus
Kawaguchi Y, Umetani S, Nitahata K, Nakiri M, Igawa T.   +4 more
europepmc   +1 more source

Successful in vitro propagation of feline coronavirus from clinically diagnosed feline infectious peritonitis cases using Vero cells: A potential model for future research

Veterinary Record Open, Volume 13, Issue 1, June 2026.
Abstract Background Feline coronavirus (FCoV) causes inapparent to progressive fatal feline infectious peritonitis (FIP) in domestic and wild cats, which affects multiple‐organ systems. Methods We investigated three clinically sick cats using different laboratory and molecular tests to diagnose and confirm FCoV and propagate the virus in Vero cell ...
Eaftekhar Ahmed Rana, Mahfuza Akther, Susan Beetson, Subir Sarker, Gabriele Rossi, Jasim M. Uddin   +5 more
wiley   +1 more source

Comparative study between female patients with functional dyspepsia accompanied by abnormal urinalysis and those with urinary tract infections: a retrospective case-control study. [PDF]

Sci Rep
Liao Y, Li Y, Wang X, Pu F, Yong G, Ming W, He G.   +6 more
europepmc   +1 more source

Safety, tolerability, pharmacokinetics and pharmacodynamics of the spleen tyrosine kinase inhibitor BI 894416 in healthy volunteers and patients with asthma

British Journal of Pharmacology, Volume 183, Issue 11, Page 2660-2674, June 2026.
Abstract Background and Purpose Spleen tyrosine kinase (SYK) has broad biological functions in inflammation and immunity. The orally administered SYK inhibitor BI 894416 was investigated in a single‐rising‐dose Phase I study in healthy volunteers and in a combined single‐ and multiple‐rising‐dose Phase Ib study in patients with mild asthma ...
Saskia Carstensen‐Aurèche, Tobias Litzenburger, Dorothy De Sousa, Reinhard Sailer, Ewald Benediktus, Denis Delic, Fabian Müller, Meike Müller, Jens M. Hohlfeld   +8 more
wiley   +1 more source

Randomised, phase 1 evaluation of the safety, tolerability, pharmacokinetics and pharmacodynamics of iptacopan in healthy volunteers

British Journal of Pharmacology, Volume 183, Issue 11, Page 2874-2889, June 2026.
Abstract Background and Purpose Overactivation of the alternative pathway (AP) underlies several diseases. Iptacopan is an oral, first‐in‐class, highly potent specific inhibitor of factor B, a key AP protease. Experimental Approach The analysis included data from two phase 1 randomised, volunteer‐blinded, placebo‐controlled studies: Study 1, a single ...
Irina Baltcheva, Guido Junge, Kenneth Kulmatycki, Robert Schmouder, Anna Schubart, Marie‐Anne Valentin   +5 more
wiley   +1 more source

Prescribing Patterns and Treatment Persistence for Overactive Bladder in Japan Across Medical Specialties and Facility Types: A Nationwide Claims Database Study. [PDF]

Int J Urol
Omae K, Hashimoto K, Maeda S.
europepmc   +1 more source